<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30657" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cutaneous Tuberculosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Charifa</surname>
            <given-names>Ahmad</given-names>
          </name>
          <aff>Yale School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mangat</surname>
            <given-names>Rupinder</given-names>
          </name>
          <aff>University of Rochester Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Oakley</surname>
            <given-names>Amanda M.</given-names>
          </name>
          <aff>University of Auckland</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmad Charifa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rupinder Mangat declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amanda Oakley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30657.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tuberculosis is an infection caused by Mycobacteria, most commonly Mycobacterium tuberculosis. This infection usually involves the lungs. When it involves the skin, it is called cutaneous tuberculosis. This activity reviews the evaluation and management of cutaneous tuberculosis and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of cutaneous tuberculosis.</p></list-item><list-item><p>Describe the common presenting features of cutaneous tuberculosis.</p></list-item><list-item><p>Identify the management options for cutaneous tuberculosis.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance the delivery of care for patients affected by cutaneous tuberculosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30657&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30657">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30657.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tuberculosis is an infection caused by <italic toggle="yes">Mycobacteria</italic>, most commonly <italic toggle="yes">Mycobacterium tuberculosis</italic>. This infection most commonly involves the lungs. When it involves the skin, it is called cutaneous tuberculosis. It is a rare disease.</p>
        <p>The history of cutaneous tuberculosis dates back to 1826 when it was first reported by Laennec. He reported a lesion on his hand that was caused by entry of the causative organism into his skin. However, the causative organism was not known until 1882 when Robert Koch first discovered <italic toggle="yes">M. tuberculosis</italic>. Later, it was&#x000a0;isolated from a cutaneous lesion of&#x000a0;an affected person.<xref ref-type="bibr" rid="article-30657.r1">[1]</xref><xref ref-type="bibr" rid="article-30657.r2">[2]</xref><xref ref-type="bibr" rid="article-30657.r3">[3]</xref></p>
        <p>
<bold>Classification</bold>
</p>
        <p>Although there are various classification systems, the most universally used&#x000a0;classification&#x000a0;of cutaneous tuberculosis variants&#x000a0;is based on the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Exogenous cutaneous tuberculosis:</italic> Tuberculous chancre and tuberculosis verrucosa cutis</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Endogenous cutaneous tuberculosis:&#x000a0;</italic>Contiguity or autoinoculation (scrofuloderma, orificial tuberculosis and some cases of lupus vulgaris); hematogenic dissemination (lupus vulgaris, tuberculous gumma, and acute miliary tuberculosis)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Tuberculids:&#x000a0;</italic>Papulonecrotic tuberculid; Lichen scrofulosorum</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Cutaneous tuberculosis:</italic>&#x000a0;Secondary to Bacillus Calmette&#x02013;Guerin vaccine (BCG) vaccination</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30657.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Infection with <italic toggle="yes">M. tuberculosis</italic> causes cutaneous tuberculosis. It is a transmittable disease that spreads from one affected person to another. It can also be caused by <italic toggle="yes">Mycobacterium bovis</italic> and BCG vaccine, less commonly.<xref ref-type="bibr" rid="article-30657.r4">[4]</xref><xref ref-type="bibr" rid="article-30657.r5">[5]</xref><xref ref-type="bibr" rid="article-30657.r6">[6]</xref></p>
      </sec>
      <sec id="article-30657.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Unlike pulmonary tuberculosis,&#x000a0;cutaneous tuberculosis is not common. Of all the patients that present with extra-pulmonary manifestations of tuberculosis, 1% to 2% suffer from cutaneous tuberculosis. It is more prevalent in parts of the world where infection with human immunodeficiency virus (HIV) is common, or where people are immunodeficient for other reasons.</p>
      </sec>
      <sec id="article-30657.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cutaneous invasion of <italic toggle="yes">M. tuberculosis</italic> causes the disease. This invasion can be exogenous or endogenous. Endogenous invasion is usually due to spread of pulmonary tuberculosis&#x000a0;by hematogenous or lymphatic dissemination. Exogenous invasion&#x000a0;is due to direct inoculation of bacteria. This leads to an immune cascade within cutaneous cells that leads to the formation of granulomas, the hallmark of tuberculosis.&#x000a0;These present with a variety of&#x000a0;clinical&#x000a0;lesions.</p>
      </sec>
      <sec id="article-30657.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Early lesions may show surface ulceration, epidermal hyperplasia, and a dense dermal infiltrate of neutrophils, lymphocytes and plasma cells. Over time, chronic inflammatory cells and granulomatous inflammation replace the neutrophils, with variable caseation necrosis. Acid-fast bacilli are usually easy to find in early lesions but are rare once granulomas develop.</p>
      </sec>
      <sec id="article-30657.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history&#x000a0;of the patient may&#x000a0;describe&#x000a0;a variety of symptoms. A patient may have pulmonary tuberculosis along with cutaneous tuberculosis and may give a history of cough, sputum, night sweats, fever, weight loss, hemoptysis, chest pain, and fatigue, among others,&#x000a0;along with cutaneous symptoms. In disseminated cutaneous tuberculosis, abdominal pain and diarrhea&#x000a0;may suggest abdominal tuberculosis. A headache may indicate tubercular meningitis. Direct inoculation of bacteria&#x000a0;presents with cutaneous symptoms&#x000a0;alone.</p>
        <p>History may also reveal immune deficiency due to underlying diseases like AIDS, uncontrolled diabetes, malignancy, and end-stage renal disease (ESRD). Other causes of immunodeficiency include intravenous drug abuse and immunosuppressive therapy.</p>
        <p>On examination, physical findings may include&#x000a0;various kinds of cutaneous lesions. There can be inflammatory papules, ulcers, nodules, pustules, verrucous plaques, or any other type of lesion.</p>
      </sec>
      <sec id="article-30657.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of suspected cutaneous tuberculosis requires history and examination along with a full workup. The workup may include&#x000a0;the tuberculosis skin test (TST) or Mantoux test, Serum QuantiFERON-TB Gold (QFT-G)&#x000a0;levels, PCR, and skin biopsy.<xref ref-type="bibr" rid="article-30657.r7">[7]</xref><xref ref-type="bibr" rid="article-30657.r8">[8]</xref><xref ref-type="bibr" rid="article-30657.r9">[9]</xref></p>
        <p>Tuberculosis skin test (TST) involves inoculation with 0.1 mL of liquid that contains purified protein derivative (PPD) into the skin. The site for the injection is the&#x000a0;superficial&#x000a0;skin of the volar wrist or forearm. The test is interpreted after a wait of 48 to 72 hours.&#x000a0;The diameter&#x000a0;of the skin induration is measured and recorded.</p>
        <p>The serum QFT-G test is an alternative to tuberculin skin test (TST). It is a blood test&#x000a0;that detects both active and latent tuberculosis by gamma interferon release assay.</p>
        <p>Skin biopsy is a reliable test for the diagnosis of cutaneous tuberculosis.&#x000a0;A skin biopsy is evaluated in 2 ways. First, slides are prepared and examined under a microscope to detect acid-fast bacilli. Second, the skin tissue is&#x000a0;cultured at low temperature&#x000a0;to detect growth of&#x000a0;<italic toggle="yes">M. tuberculosis</italic>. Culture is the gold standard for diagnosis of tuberculosis.</p>
        <p>Other tests that can help with diagnosis include a chest x-ray and sputum examination. Sputum examination involves microscopy for AfB and&#x000a0;culture.</p>
      </sec>
      <sec id="article-30657.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of cutaneous tuberculosis is the same as treatment of systemic tuberculosis. It also involves multidrug treatment. The drugs that are most commonly used&#x000a0;are isoniazid, rifampicin, pyrazinamide, and ethambutol or streptomycin. The treatment consists of 2 phases.</p>
        <list list-type="bullet">
          <list-item>
            <p>An intensive phase that involves rapidly decreasing the burden of <italic toggle="yes">M. tuberculosis</italic></p>
          </list-item>
          <list-item>
            <p>A continuation phase that is also called the sterilizing phase</p>
          </list-item>
        </list>
        <p>The intensive phase of therapy lasts&#x000a0;about 8 weeks. After this phase, the patient no longer remains infectious, but he or she still requires more treatment&#x000a0;to eradicate the infection. The&#x000a0;continuation phase is designed to eradicate remaining bacteria&#x000a0;and lasts for 9&#x000a0;to 12 months. Cure of tuberculosis&#x000a0;requires the patient to adhere to treatment strictly.</p>
        <p>Results of treatment&#x000a0;depend on the immunity of a patient, their overall health, the stage of the disease, the type of cutaneous lesions, the patient&#x02019;s compliance, duration of treatment, and any side effects experienced.</p>
      </sec>
      <sec id="article-30657.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of cutaneous tuberculosis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic vegetative pyoderma</p>
          </list-item>
          <list-item>
            <p>Blastomycosis</p>
          </list-item>
          <list-item>
            <p>Chromoblastomycosis</p>
          </list-item>
          <list-item>
            <p>Drug reactions</p>
          </list-item>
          <list-item>
            <p>Granulomatosis with polyangiitis (Wegener granulomatosis)</p>
          </list-item>
          <list-item>
            <p>Granulomatous rosacea</p>
          </list-item>
          <list-item>
            <p>Syphilitic gumma</p>
          </list-item>
          <list-item>
            <p>Keratosis spinulosa</p>
          </list-item>
          <list-item>
            <p>Papular eczema</p>
          </list-item>
          <list-item>
            <p>Coccidioidomycosis</p>
          </list-item>
          <list-item>
            <p>Glossitis</p>
          </list-item>
          <list-item>
            <p>Atypical mycobacterial infection</p>
          </list-item>
          <list-item>
            <p>Chronic granulomatous disease</p>
          </list-item>
          <list-item>
            <p>Lupoid rosacea</p>
          </list-item>
          <list-item>
            <p>Nodular vasculitis (Weber-Christian disease)</p>
          </list-item>
          <list-item>
            <p>Nodular pernio</p>
          </list-item>
        </list>
        <p>Many different diseases can be included in differential diagnosis depending on the presentation of cutaneous tuberculosis. It is difficult to make a diagnosis of this disease because of its resemblance with many other cutaneous lesions.</p>
      </sec>
      <sec id="article-30657.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of&#x000a0;cutaneous tuberculosis is good in patients who are not immunocompromised. However, even aggressive treatment may not be effective in patients who are immunocompromised and where the organisms are multidrug resistant.</p>
      </sec>
      <sec id="article-30657.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>
<bold>Prevention</bold>
</p>
        <p>Prevention of cutaneous tuberculosis involves BCG vaccination; identification, separation, and treatment of the person who is a source of infection; and use of sterilized instruments, along with other steps. As immunodeficiency is the biggest cause of skin tuberculosis, one should try to avoid&#x000a0;it by controlling diabetes and other diseases. In cases where drug therapy is the cause of immunodeficiency, pretesting and treating latent&#x000a0;tuberculosis with antibiotics are indicated.</p>
        <p>
<bold>Compliance</bold>
</p>
        <p>Compliance with treatment recommendations is essential when it comes to treating tuberculosis. A patient who is not compliant may&#x000a0;cause the organisms to be&#x000a0;drug resistant. Multiple therapies may be needed, and in such patients, directly observed treatment (DOT) is recommended.</p>
      </sec>
      <sec id="article-30657.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Cutaneous tuberculosis may present to the nurse practitioner or primary care provider. Since the skin features are not always obvious, the patient should be referred to an infectious disease consult, dermatologist or an internist. The management of cutaneous tuberculosis is the same as treatment of systemic tuberculosis. It also involves multidrug treatment. The drugs that are most commonly used&#x000a0;are isoniazid, rifampicin, pyrazinamide, and ethambutol or streptomycin. The treatment consists of 2 phases.</p>
        <list list-type="bullet">
          <list-item>
            <p>An intensive phase that involves rapidly decreasing the burden of&#x000a0;<italic toggle="yes">M. tuberculosis</italic></p>
          </list-item>
          <list-item>
            <p>A continuation phase that is also called the sterilizing phase</p>
          </list-item>
        </list>
        <p>Results of treatment&#x000a0;depend on the immunity of a patient, their overall health, the stage of the disease, the type of cutaneous lesions, the patient&#x02019;s compliance, duration of treatment, and any side effects experienced.<xref ref-type="bibr" rid="article-30657.r10">[10]</xref><xref ref-type="bibr" rid="article-30657.r11">[11]</xref></p>
      </sec>
      <sec id="article-30657.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30657&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30657">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/cutaneous-tuberculosis-tb-skin-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30657">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30657/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30657">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30657.s15">
        <fig id="article-30657.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tongue of Tuberculosis Patient. Lesion caused by Mycobacterium tuberculosis, erythematous connective tissue, eroded mucocutaneous membrane of the tongue. Contributed by RE Sumpter, Centers for Disease Control and Prevention&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="14817_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30657.s16">
        <title>References</title>
        <ref id="article-30657.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haitz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic granulomatous mastitis.</article-title>
            <source>Cutis</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-42</page-range>
            <pub-id pub-id-type="pmid">30758334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mello</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>ECSD</given-names>
              </name>
              <name>
                <surname>Baeta</surname>
                <given-names>IGR</given-names>
              </name>
            </person-group>
            <article-title>Scrofuloderma: a diagnostic challenge.</article-title>
            <source>An Bras Dermatol</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-104</page-range>
            <pub-id pub-id-type="pmid">30726475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Cahalane</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Case 2-2019: A 36-Year-Old Man with Rash, Abdominal Pain, and Lymphadenopathy.</article-title>
            <source>N Engl J Med</source>
            <year>2019</year>
            <month>Jan</month>
            <day>17</day>
            <volume>380</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-283</page-range>
            <pub-id pub-id-type="pmid">30650323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alwunais</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schachner</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>An interesting case of coincidental epidermolytic hyperkeratosis and erythema annulare centrifugum in the setting of latent tuberculosis in a 12-year-old female.</article-title>
            <source>Int J Dermatol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>11</issue>
            <fpage>1337</fpage>
            <page-range>1337-1340</page-range>
            <pub-id pub-id-type="pmid">30623423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeo</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SX</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Sng</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, risk factors, and outcomes of adult cutaneous non-tuberculous mycobacterial infection over a 10-year period in Singapore.</article-title>
            <source>Int J Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>679</fpage>
            <page-range>679-687</page-range>
            <pub-id pub-id-type="pmid">30585309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singaraddi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Primary cutaneous 'ulcerative' tuberculosis of the scrotum: a rare occurrence.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <day>19</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30573537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franco-Paredes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marcos</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Henao-Mart&#x000ed;nez</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Morales</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Villamil-G&#x000f3;mez</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Gotuzzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Mycobacterial Infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30429139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Errichetti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stinco</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Dermatoscopy of Granulomatous Disorders.</article-title>
            <source>Dermatol Clin</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>369</fpage>
            <page-range>369-375</page-range>
            <pub-id pub-id-type="pmid">30201146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khadka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koirala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thapaliya</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Tuberculosis: Clinicopathologic Arrays and Diagnostic Challenges.</article-title>
            <source>Dermatol Res Pract</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>7201973</fpage>
            <pub-id pub-id-type="pmid">30111996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Zyl</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>du Plessis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Viljoen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous tuberculosis overview and current treatment regimens.</article-title>
            <source>Tuberculosis (Edinb)</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>629</fpage>
            <page-range>629-638</page-range>
            <pub-id pub-id-type="pmid">26616847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30657.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellet</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Prose</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Skin complications of Bacillus Calmette-Gu&#x000e9;rin immunization.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-100</page-range>
            <pub-id pub-id-type="pmid">15735410</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
